Zepbound and Mounjaro posted triple-digit revenue growth, making Lilly the first health-care firm to reach a trillion-dollar valuation. Silicon Valley’s giants crowd the list of the world’s most valuable companies, but drugmaker Eli Lilly is hot on their heels. The company topped a market capitalization of one trillion dollars on Friday, becoming the first business in the health industry to hit that milestone.